October 5, 2015

Novocure Announces CE Mark and First Patient Use of Second Generation Optune System

The newly designed, second generation Optune system incorporates state of the art digital technology and is more than 50% lighter and 50% smaller than the first generation system The newly designed, second generation Optune system incorporates state of the art digital technology and is more than 50%… Read More
learn more
October 2, 2015

NovoCure Limited Announces Launch of Initial Public Offering

October 01, 2015 09:07 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–NovoCure Limited, a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares of its common… Read More
learn more
October 2, 2015

NovoCure Limited Announces Launch of Initial Public Offering

October 01, 2015 09:07 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–NovoCure Limited, a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares of its common… Read More
learn more
October 2, 2015

NovoCure Limited Announces Launch of Initial Public Offering

October 01, 2015 09:07 PM Eastern Daylight Time ST. HELIER, Jersey–(BUSINESS WIRE)–NovoCure Limited, a commercial stage oncology company pioneering a novel therapy for solid tumors, announced today the launch of its initial public offering of 12,500,000 shares of its common… Read More
learn more